Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospectiv...
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
About this item
Full title
Author / Creator
Neuromyelitis Optica Study Group , Neuromyelitis Optica Study Group (NEMOS) , Ayzenberg, Ilya , Schöllhammer, Joanna , Hoepner, Robert , Hellwig, Kerstin , Ringelstein, Marius , Aktas, Orhan , Kümpfel, Tania , Krumbholz, Markus , Trebst, Corinna , Paul, Friedemann , Pache, Florence , Obermann, Mark , Zeltner, Lena , Schwab, Matthias , Berthele, Achim , Jarius, Sven and Kleiter, Ingo
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Glatiramer acetate (GA) is an approved therapy for relapsing–remitting multiple sclerosis, but its efficacy for the prevention of attacks in neuromyelitis optica spectrum disorder (NMOSD) remains unknown. We did a multicenter retrospective analysis of GA-treated patients with NMOSD, identified through a national registry. Annualized relapse rate an...
Alternative Titles
Full title
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
Authors, Artists and Contributors
Author / Creator
Neuromyelitis Optica Study Group (NEMOS)
Ayzenberg, Ilya
Schöllhammer, Joanna
Hoepner, Robert
Hellwig, Kerstin
Ringelstein, Marius
Aktas, Orhan
Kümpfel, Tania
Krumbholz, Markus
Trebst, Corinna
Paul, Friedemann
Pache, Florence
Obermann, Mark
Zeltner, Lena
Schwab, Matthias
Berthele, Achim
Jarius, Sven
Kleiter, Ingo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1776657536
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1776657536
Other Identifiers
ISSN
0340-5354
E-ISSN
1432-1459
DOI
10.1007/s00415-015-7991-1
